{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T18:30:16Z","timestamp":1778610616642,"version":"3.51.4"},"reference-count":55,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>The objective of the study was to compare the efficacy and safety of antifungal agents used in the prevention of oropharyngeal candidiasis among HIV-infected adults. A systematic search was conducted in four databases (MEDLINE, Scopus, CENTRAL, and Embase) for eligible randomized control trials (RCTs). The network meta-analyses (NMA) were performed using a random-effects model. Interventions were ranked based on the efficacy and safety using the surface under the cumulative ranking curve (SUCRA). The quality of evidence was assessed using the GRADE approach. From a total of 1574 studies screened, 7 RCTs comprising 959 participants were included in NMA. The use of fluconazole as a prophylactic agent was associated with a significant reduction in incidence of OPC compared to placebo (RR, 0.45 (95% CI: 0.27\u20130.77)) in HIV-infected adults. The overall quality of evidence was graded as moderate. Fluconazole was ranked the best antifungal for efficacy (SUCRA\u201495.6%) as well as safety (SUCRA\u201439.3%) in HIV-infected adults. Overall, the quality of evidence was graded as moderate. Fluconazole can be considered as an effective agent with a better safety profile for the prophylaxis of OPC in HIV-infected adults. However, similar to any other antimicrobial agent, the risk of possibility of resistance must be weighed against the benefits.<\/jats:p>","DOI":"10.3390\/life12040515","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:34:29Z","timestamp":1648762469000},"page":"515","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparative Efficacy and Safety of Antifungal Agents in the Prophylaxis of Oropharyngeal Candidiasis among HIV-Infected Adults: A Systematic Review and Network Meta-Analysis"],"prefix":"10.3390","volume":"12","author":[{"given":"Shamala Gopal","family":"Rajadurai","sequence":"first","affiliation":[{"name":"School of Postgraduate Studies, International Medical University, Kuala Lumpur 57000, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6812-0533","authenticated-orcid":false,"given":"Mari Kannan","family":"Maharajan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, School of Pharmacy, International Medical University, Kuala Lumpur 57000, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajesh K.","family":"Veettil","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT 84112, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4279-7420","authenticated-orcid":false,"given":"Divya","family":"Gopinath","sequence":"additional","affiliation":[{"name":"Clinical Oral Health Sciences, International Medical University, Kuala Lumpur 57000, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408418709104444","article-title":"Candida Infections: An Overview","volume":"15","author":"Odds","year":"1987","journal-title":"CRC Crit. Rev. Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3389\/fmicb.2015.01391","article-title":"Clinical Appearance of Oral Candida Infection and Therapeutic Strategies","volume":"6","author":"Patil","year":"2015","journal-title":"Front. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0030-4220(90)90265-T","article-title":"Antifungal Therapy in Oropharyngeal Mycotic Infections","volume":"69","author":"Epstein","year":"1990","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Rajadurai, S.G., Maharajan, M.K., Veettil, S.K., and Gopinath, D. (2021). Comparative Efficacy of Antifungal Agents Used in the Treatment of Oropharyngeal Candidiasis among HIV-Infected Adults: A Systematic Review and Network Meta-Analysis. J. Fungi, 7.","DOI":"10.3390\/jof7080637"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/odi.13588","article-title":"Antifungal agents in preventing oral candidiasis in clinical oncology: A network meta-analysis","volume":"27","author":"Loo","year":"2021","journal-title":"Oral Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/00016359009012736","article-title":"Factors Predisposing to Oral Yeast Infections","volume":"48","author":"Oksala","year":"1990","journal-title":"Acta Odontol. Scand."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1034\/j.1399-302x.2001.016005270.x","article-title":"Salivary Anticandidal Activity and Saliva Composition in an HIV-Infected Cohort","volume":"16","author":"Lin","year":"2001","journal-title":"Oral Microbiol. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1600-0714.1989.tb01552.x","article-title":"Oral Candidiasis and Human Immunodeficiency Virus Infection","volume":"18","author":"Samaranayake","year":"1989","journal-title":"J. Oral Pathol. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0030-4220(92)90191-R","article-title":"Oral Mycoses in HIV Infection","volume":"73","author":"Samaranayake","year":"1992","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1128\/CMR.17.4.729-759.2004","article-title":"Immunopathogenesis of Oropharyngeal Candidiasis in Human Immunodeficiency Virus Infection","volume":"17","author":"Lewandowski","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1601-0825.2003.00994.x","article-title":"Effect of PI-HAART on the Prevalence of Oral Lesions in HIV-1 Infected Patients. A Greek Study","volume":"10","author":"Velegraki","year":"2004","journal-title":"Oral Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.tripleo.2007.12.024","article-title":"Do oral lesions associated with HIV affect quality of life?","volume":"106","author":"Yengopal","year":"2008","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1056\/NEJM199503163321102","article-title":"A Randomized Trial Comparing Fluconazole with Clotrimazole Troches for the Prevention of Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection. NIAID AIDS Clinical Trials Group","volume":"332","author":"Powderly","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0964-1955(94)90091-4","article-title":"Value of Antifungal Prophylaxis with Antifungal Drugs against Oropharyngeal Candidiasis in Cancer Patients","volume":"30","author":"Meunier","year":"1994","journal-title":"Eur. J. Cancer Part B Oral Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/00042560-199608150-00005","article-title":"Prophylaxis with Nystatin Pastilles for HIV-Associated Oral Candidiasis","volume":"12","author":"MacPhail","year":"1996","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. Off. Publ. Int. Retrovirol. Assoc."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1086\/514744","article-title":"Itraconazole Prophylaxis for Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection: Randomized, Placebo-Controlled, Double-Blind Study","volume":"28","author":"McKinsey","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"ref_17","unstructured":"(2021, March 03). Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV, Available online: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/adult-and-adolescent-opportunistic-infection\/candidiasis-mucocutaneous?view=full."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1067\/moe.2001.116600","article-title":"A Systematic Review of the Effectiveness of Antifungal Drugs for the Prevention and Treatment of Oropharyngeal Candidiasis in HIV-Positive Patients","volume":"92","author":"Patton","year":"2001","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.331.7521.897","article-title":"Simultaneous Comparison of Multiple Treatments: Combining Direct and Indirect Evidence","volume":"331","author":"Caldwell","year":"2005","journal-title":"BMJ"},{"key":"ref_20","unstructured":"(2020, December 26). Cochrane Handbook for Systematic Reviews of Interventions. Available online: https:\/\/training.cochrane.org\/handbook\/current."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-Analyses of Health Care Interventions: Checklist and Explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A Revised Tool for Assessing Risk of Bias in Randomised Trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"g5630","DOI":"10.1136\/bmj.g5630","article-title":"A GRADE Working Group Approach for Rating the Quality of Treatment Effect Estimates from Network Meta-Analysis","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ"},{"key":"ref_24","unstructured":"(2020, December 28). Chapter 10: Analysing Data and Undertaking Meta-Analyses. Available online: https:\/\/training.cochrane.org\/handbook\/current\/chapter-10."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jval.2011.01.011","article-title":"Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2","volume":"14","author":"Hoaglin","year":"2011","journal-title":"Value Health"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical Methods and Numerical Summaries for Presenting Results from Multiple-Treatment Meta-Analysis: An Overview and Tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1086\/497373","article-title":"AIDS Clinical Trials Group Study Team 323; Mycoses Study Group Study Team 40. A Randomized Study of the Use of Fluconazole in Continuous versus Episodic Therapy in Patients with Advanced HIV Infection and a History of Oropharyngeal Candidiasis: AIDS Clinical Trials Group Study 323\/Mycoses Study Group Study 40","volume":"41","author":"Goldman","year":"2005","journal-title":"Clin Infect Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1601-0825.2008.01449.x","article-title":"A Randomized Clinical Trial of Chlorhexidine in the Maintenance of Oral Candidiasis-Free Period in HIV Infection","volume":"14","author":"Nittayananta","year":"2008","journal-title":"Oral Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0163-4453(90)90646-P","article-title":"Once-Weekly Fluconazole to Prevent Recurrence of Oropharyngeal Candidiasis in Patients with AIDS and AIDS-Related Complex: A Double-Blind Placebo-Controlled Study","volume":"21","author":"Leen","year":"1990","journal-title":"J. Infect."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/BF02005444","article-title":"Fluconazole Prophylaxis of Recurrent Oral Candidiasis in HIV-Positive Patients","volume":"10","author":"Gentschew","year":"1991","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1001\/archinte.1991.00400120096018","article-title":"Thrush Can Be Prevented in Patients with Acquired Immunodeficiency Syndrome and the Acquired Immunodeficiency Syndrome-Related Complex: Randomized, Double-Blind, Placebo-Controlled Study of 100-Mg Oral Fluconazole Daily","volume":"151","author":"Stevens","year":"1991","journal-title":"Arch. Intern. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5694\/j.1326-5377.1993.tb121784.x","article-title":"Fluconazole Once a Week as Secondary Prophylaxis against Oropharyngeal Candidiasis in HIV-Infected Patients. A Double-Blind Placebo-Controlled Study","volume":"158","author":"Marriott","year":"1993","journal-title":"Med. J. Aust."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-126-9-199705010-00003","article-title":"Weekly Fluconazole for the Prevention of Mucosal Candidiasis in Women with HIV Infection. A Randomized, Double-Blind, Placebo-Controlled Trial. Terry Beirn Community Programs for Clinical Research on AIDS","volume":"126","author":"Schuman","year":"1997","journal-title":"Ann. Intern. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/jac\/dkf101","article-title":"Efficacy, Tolerability and Development of Resistance in HIV-Positive Patients Treated with Fluconazole for Secondary Prevention of Oropharyngeal Candidiasis: A Randomized, Double-Blind, Placebo-Controlled Trial","volume":"50","author":"Pagani","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0002-9343(98)00137-5","article-title":"A Randomized Trial of Continuous or Intermittent Therapy with Fluconazole for Oropharyngeal Candidiasis in HIV-Infected Patients: Clinical Outcomes and Development of Fluconazole Resistance","volume":"105","author":"Revankar","year":"1998","journal-title":"Am. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"844069","DOI":"10.3389\/fmicb.2022.844069","article-title":"Epidemiology and Prevalence of Oral Candidiasis in HIV Patients From Chad in the Post-HAART Era","volume":"13","author":"Kuhns","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/154407370601900126","article-title":"(B3) Markers of Immunodeficiency and Mechanisms of HAART Therapy on Oral Lesions","volume":"19","author":"Flint","year":"2006","journal-title":"Adv. Dent. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.tripleo.2009.11.026","article-title":"Oropharyngeal Candidiasis in the Era of Antiretroviral Therapy","volume":"109","author":"Thompson","year":"2010","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"ref_39","first-page":"CD003940","article-title":"Interventions for the Prevention and Management of Oropharyngeal Candidiasis Associated with HIV Infection in Adults and Children","volume":"11","author":"Pienaar","year":"2010","journal-title":"Cochrane Database Syst. Rev. Online"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/hiv.12806","article-title":"British HIV Association Guidelines on the Management of Opportunistic Infection in People Living with HIV: The Clinical Management of Candidiasis 2019","volume":"20","author":"Dockrell","year":"2019","journal-title":"HIV Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fmed.2016.00011","article-title":"Emerging Threats in Antifungal-Resistant Fungal Pathogens","volume":"3","author":"Sanglard","year":"2016","journal-title":"Front. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1099\/jmm.0.000123","article-title":"Overexpression and Mutation as a Genetic Mechanism of Fluconazole Resistance in Candida Albicans Isolated from Human Immunodeficiency Virus Patients in Indonesia","volume":"64","author":"Rosana","year":"2015","journal-title":"J. Med. Microbiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1079-2104(98)90291-8","article-title":"Fluconazole-Resistant Candida Species in the Oral Flora of Fluconazole-Exposed HIV-Positive Patients","volume":"85","author":"Hunter","year":"1998","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/clinids\/24.1.28","article-title":"Infection Due to Fluconazole-Resistant Candida in Patients with AIDS: Prevalence and Microbiology","volume":"24","author":"Maenza","year":"1997","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1128\/AAC.01657-09","article-title":"Systematic Review and Meta-Analysis of the Tolerability and Hepatotoxicity of Antifungals in Empirical and Definitive Therapy for Invasive Fungal Infection","volume":"54","author":"Wang","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"682","DOI":"10.5588\/ijtld.13.0729","article-title":"Role of Oral Candidiasis in TB and HIV Co-Infection: AIDS Clinical Trial Group Protocol A5253","volume":"18","author":"Shiboski","year":"2014","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2165\/00003088-200443110-00003","article-title":"Effect of Rifampicin on the Pharmacokinetics of Fluconazole in Patients with AIDS","volume":"43","author":"Thanompuangseree","year":"2004","journal-title":"Clin. Pharmacokinet."},{"key":"ref_48","first-page":"56","article-title":"Drug Interactions with Tuberculosis Therapy","volume":"23","author":"Swart","year":"2008","journal-title":"Contin. Med. Educ."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0140-6736(03)14472-8","article-title":"Echinocandin Antifungal Drugs","volume":"362","author":"Denning","year":"2003","journal-title":"Lancet"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/odi.13469","article-title":"The global changing pattern of the oral manifestations of HIV","volume":"26","author":"Tappuni","year":"2020","journal-title":"Oral Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/odi.13386","article-title":"Global inequalities in HIV infection","volume":"26","author":"Challacombe","year":"2020","journal-title":"Oral Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e12351","DOI":"10.1111\/jicd.12351","article-title":"Systematic review of the changing pattern of the oral manifestations of HIV","volume":"9","author":"Tappuni","year":"2018","journal-title":"J. Investig. Clin. Dent."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Solomon, F.B., Angore, B.N., Koyra, H.C., Tufa, E.G., Berheto, T.M., and Admasu, M. (2018). Spectrum of opportunistic infections and associated factors among people living with HIV\/AIDS in the era of highly active anti-retroviral treatment in Dawro Zone hospital: A retrospective study. BMC Res. Notes, 11.","DOI":"10.1186\/s13104-018-3707-9"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2155-6113.1000301","article-title":"Prevalence of Opportunistic Infections and Associated Factors among HIV Positive Patients taking AntiRetroviral Therapy in DebreMarkos Referral Hospital, Northwest Ethiopia","volume":"5","author":"Moges","year":"2014","journal-title":"J. AIDS Clin. Res."},{"key":"ref_55","first-page":"002","article-title":"Prevalence and risk factors for opportunistic infections in HIV patients receiving antiretroviral therapy in a resource-limited setting in Nigeria","volume":"S3","author":"Iroezindu","year":"2013","journal-title":"J. AIDS Clin. Res."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/12\/4\/515\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:47:13Z","timestamp":1760136433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/12\/4\/515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,31]]},"references-count":55,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["life12040515"],"URL":"https:\/\/doi.org\/10.3390\/life12040515","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,31]]}}}